Shopping Cart
- Remove All
Your shopping cart is currently empty
EMI48, a derivative of EMI1, exhibits increased efficacy against mutant EGFR compared to EMI1. It specifically inhibits EGFR triple mutants [1].

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $259 | 6-8 weeks | |
| 25 mg | $893 | 6-8 weeks | |
| 50 mg | $1,160 | 6-8 weeks | |
| 100 mg | $1,650 | 6-8 weeks | |
| 1 mL x 10 mM (in DMSO) | $272 | 6-8 weeks |
| Description | EMI48, a derivative of EMI1, exhibits increased efficacy against mutant EGFR compared to EMI1. It specifically inhibits EGFR triple mutants [1]. |
| In vitro | EMI48 effectively targets and inhibits the EGFR ex19del/T790M/C797S and EGFR L858R/T790M/C797S mutations, making it a valuable agent in the study of mutant EGFR-associated, drug-resistant non-small-cell lung cancer (NSCLC) [1]. |
| Molecular Weight | 348.4 |
| Formula | C21H20N2O3 |
| Cas No. | 34564-13-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.